ICD-10-CM Diagnosis Code for Malignant Neoplasm of Upper Outer Quadrant of Right Breast, Estrogen Receptor Positive, Female
The appropriate ICD-10-CM diagnosis code is C50.411 (Malignant neoplasm of upper-outer quadrant of right breast, female).
Primary Diagnosis Code
The base code C50.411 specifically identifies:
- Anatomic location: Upper-outer quadrant
- Laterality: Right breast
- Sex: Female
- Pathology: Malignant neoplasm
This code follows the hierarchical structure of ICD-10-CM where C50 represents malignant neoplasm of breast, with subsequent digits specifying the exact quadrant and laterality 1, 2.
Additional Required Code for Estrogen Receptor Status
You must also assign Z17.0 to indicate estrogen receptor positive status. This is a mandatory secondary code that captures the critical biomarker information essential for treatment planning 1, 3.
The estrogen receptor status is not embedded in the primary malignancy code but requires separate documentation because:
- ER status is a predictive factor for endocrine therapy response, not merely a prognostic factor 4, 5
- This information directly influences treatment decisions between endocrine therapy versus chemotherapy 5
- Guidelines mandate ER/PR determination preferably by immunohistochemistry for all breast cancer cases 1, 2, 6
Complete Coding
Primary code: C50.411
Secondary code: Z17.0
Important Coding Considerations
Pathological Confirmation Required
The diagnosis should be based on core needle biopsy with immunohistochemical evaluation confirming ER-positive status (≥1% cells positive) before coding 1, 2. The guidelines emphasize that a core needle biopsy is mandatory before any treatment is initiated 1, 2.
Additional Codes to Consider
Depending on the clinical scenario, you may need additional codes for:
- HER2 status (if positive, requires separate documentation)
- Progesterone receptor status (if tested)
- TNM staging (once surgical pathology is available)
- Grade (once determined histologically)
Common Pitfall to Avoid
Do not use unspecified breast codes (C50.919) when the specific quadrant and laterality are known. ICD-10-CM provides granular anatomic detail that should be utilized when documented 7. The upper-outer quadrant is the most common site for breast cancer and should be specifically coded when identified.
Clinical Context
This coding combination identifies a patient eligible for endocrine therapy as first-line treatment, which is the standard approach for hormone receptor-positive breast cancer 5, 3. The ER-positive status (captured by Z17.0) indicates the tumor will likely respond to tamoxifen, aromatase inhibitors, or other endocrine therapies depending on menopausal status 5, 3.